About
Oat fiber is a dietary fiber ingredient derived from the oat grain (Avena sativa), encompassing both insoluble hull fiber and soluble beta-glucan fractions. It is used as a bulking agent, fat replacer, and functional food ingredient prized for its scientifically supported cholesterol-lowering and blood-glucose-modulating properties.
Safety summary
Oat fiber has an excellent safety profile; no Acceptable Daily Intake (ADI) has been established and it holds GRAS status in the United States. The principal risk for sensitive individuals is potential cross-contamination with gluten-containing grains (wheat, barley, rye) during processing, posing a hazard to those with celiac disease or non-celiac gluten sensitivity. High intakes may cause transient gastrointestinal effects such as bloating and flatulence in some individuals.
Regulatory landscape
| Jurisdiction | Status | Note |
|---|---|---|
| EFSA (European Food Safety Authority) (European Union) | Approved | Oat grain fiber carries an authorised health claim for contribution to increased faecal bulk under Commission Regulation (EU) 432/2012. Oat beta-glucans are separately authorised for (1) maintenance of normal blood cholesterol levels at ≥3 g/day and (2) reduction of postprandial blood glucose peaks at ≥3 g per 30 g available carbohydrates. Oat fiber is not assigned an E number as it is classified as a food ingredient rather than a food additive under EU law.source |
| FDA (Food and Drug Administration) (United States) | Approved | Oat hull fiber recognized as GRAS (GRN 000261) for use as an anti-caking agent in powdered organic acids and oleoresin-containing injectable brines; broader dietary fiber use is widely accepted. FDA issued a separate authorised cardiovascular health claim for whole oats (beta-glucan soluble fiber) in 1997 under 21 CFR 101.81.source |
Who should approach with care
Research citations
- 1EFSA. Oat beta-glucans and reduction of postprandial glucose peak: Evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006, 2026. efsa.europa.eu
- 2PubMed. A Randomized Placebo-Controlled Clinical Trial to Evaluate the Medium-Term Effects of Oat Fibers on Human Health: The Beta-Glucan Effects on Lipid Profile, Glycemia and inTestinal Health (BELT) Study, 2020. pubmed.ncbi.nlm.nih.gov
- 3FDA. Agency Response Letter GRAS Notice No. GRN 000261 – Oat Hull Fiber (Grain Millers, Inc.), 2018. fda.gov
- 4EFSA. EU Register on Nutrition and Health Claims – Oat Grain Fibre and Oat Beta-Glucans (Commission Regulation (EU) 432/2012), 2012. ec.europa.eu
- 5PubMed. Concentrated oat β-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial, 2007. pmc.ncbi.nlm.nih.gov
